Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Inventory Average (2022 - 2025)

Historic Inventory Average for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $21.1 million.

  • Axsome Therapeutics' Inventory Average rose 4317.45% to $21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year increase of 4317.45%. This contributed to the annual value of $15.4 million for FY2024, which is 5865.84% up from last year.
  • According to the latest figures from Q3 2025, Axsome Therapeutics' Inventory Average is $21.1 million, which was up 4317.45% from $17.4 million recorded in Q2 2025.
  • Over the past 5 years, Axsome Therapeutics' Inventory Average peaked at $21.1 million during Q3 2025, and registered a low of $6.1 million during Q1 2023.
  • Its 4-year average for Inventory Average is $13.3 million, with a median of $14.7 million in 2024.
  • Its Inventory Average has fluctuated over the past 5 years, first tumbled by 2087.4% in 2023, then skyrocketed by 15055.46% in 2024.
  • Axsome Therapeutics' Inventory Average (Quarter) stood at $9.2 million in 2022, then skyrocketed by 37.21% to $12.6 million in 2023, then increased by 19.41% to $15.0 million in 2024, then skyrocketed by 40.73% to $21.1 million in 2025.
  • Its Inventory Average was $21.1 million in Q3 2025, compared to $17.4 million in Q2 2025 and $16.0 million in Q1 2025.